Delivery Order SPE2DB20D1109-SPE2DB22FP22J
Award Date
5/13/22
Potential Completion Date
5/16/22
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $1,865.62. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,032.24 firm fixed-price delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (180 ml) to the Defense Logistics Agency (DLA). The $1,658.28 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on December 13, 2022 with a completion date of December 14, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (60 ml) to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The single-award, firm-fixed-price delivery order, valued at $1,524.36, was issued to the Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on August 11, 2021, with a ceiling value of $2,910.20. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,688.86 and a period of performance ending on January 22, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Quillivant XR 25 mg/5 ml oral suspension drug product. The contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company, for a ceiling value of $2,431.85. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,344.65 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a vehicle for the company to supply a broad range of pharmaceutical products and...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (180 ml) to the Defense Logistics Agency (DLA). The $4,600.08 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has no set-aside designation, indicating open...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,419.60, was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract does not have a set-aside designation, indicating open...